ipharmaservicesAug 4, 2022Keytruda failed to meet the primary endpoints in mCRPC and 1L uHCC | iParmaCenter
ipharmaservicesJan 17, 2022Breast Cancer News | Blogs | Keytruda, Trodelvy was approved for TNBC | iPhamaCenter
ipharmaservicesSep 18, 2020To strengthen the oncology portfolio, Merck collaborated with Seattle Genetics, and Gilead acquired